FERROZINC-G

This brand name is authorized in Turkey

Active ingredients

The drug FERROZINC-G contains a combination of these active pharmaceutical ingredients (APIs):

1 Ferrous gluconate
UNII U1B11I423Z - FERROUS GLUCONATE

Iron is an essential constituent of the body, being necessary for haemoglobin formation and for the oxidative processes of living tissues. More than 80% of the iron present in the body is involved in the support of red blood cell production. Ferrous gluconate is indicated for the prevention and treatment of iron deficiency states.

Read about Ferrous gluconate
2 Zinc gluconate
UNII U6WSN5SQ1Z - ZINC GLUCONATE
Read about Zinc gluconate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B03AE10 Various combinations B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AE Iron in other combinations
Discover more medicines within B03AE10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8699591570355

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈